
Nightingale Health
A blood testing company bringing extensive biological data to routine healthcare.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
€8.8m | Angel | ||
Total Funding | 000k |
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 15 % | - | 81 % | 4 % | 8 % | 58 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (181 %) | (394 %) | (278 %) | (211 %) | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (422 %) | (696 %) | (432 %) | (401 %) | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | 15 % | 53 % | 14 % | 5 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Nightingale Health provides a comprehensive health data platform that focuses on preventative healthcare. The company has developed a proprietary blood analysis technology that delivers biomarker data from a single blood sample. This technology is utilized to provide health checks and risk prediction models for chronic diseases.
The company's strategy is centered on the business-to-business (B2B) and business-to-government (B2G) markets. In the B2B sector, Nightingale Health collaborates with private healthcare providers, such as Terveystalo in occupational health, to integrate its technology into their services. The B2G approach involves partnerships with public healthcare systems to implement preventative health initiatives.
Nightingale Health's business model is driven by the global trends of increasing consumer investment in health and wellbeing, the rising prevalence of chronic diseases, and the growing strain on traditional healthcare systems. The company's revenue is generated by providing its advanced health check and data analysis services to its partners in the private and public sectors.
Keywords: health data platform, preventative healthcare, blood analysis, biomarker data, risk prediction, chronic diseases, B2B, B2G, occupational health, public health
Tech stack
Investments by Nightingale Health
Edit

